市场调查报告书
商品编码
1495467
内闭合装置市场:依产品、最终用户划分 - 2024-2030 年全球预测Endoscopic Closure Devices Market by Product (Band Ligators, Clips, Suturing Devices), End-user (Ambulatory Surgical Centers, Hospitals) - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年内闭合装置市场规模为5.0975亿美元,预计2024年将达到5.3815亿美元,2030年将达到7.6093亿美元,复合年增长率为5.88%。
内视镜闭合装置用于在内视镜手术期间或之后闭合胃肠道中的穿孔、切口和管腔。这些工具对于内视镜切除、胃肠道缺陷治疗以及需要暂时或永久闭合肠壁开口的手术等手术至关重要。胃肠道疾病的日益普及增加了相关手术的偏好,导致内视镜闭合装置闭合装置的需求不断扩大。先进内视镜闭合装置的高成本阻碍了市场成长。具有能够与医疗保健系统整合以实现更好的资料管理和病患监测功能的内视镜闭合装置市场正在开拓中,预计将为市场成长创造机会。
主要市场统计 | |
---|---|
基准年[2023] | 50975万美元 |
预测年份 [2024] | 5.3815亿美元 |
预测年份 [2030] | 76093万美元 |
复合年增长率(%) | 5.88% |
区域洞察
由于先进的医疗基础设施和消化器官系统手术的高发生率,美洲是内视镜闭合装置不断增长的市场。美洲消费者对微创手术的认识更加深刻,对内视镜闭合装置的需求也日益增长。南美洲内视闭合装置市场得到了政府和私营部门旨在减少手术时间和改善恢復期的倡议的支持。欧盟国家的内视镜闭合装置市场受到严格的欧盟法规的推动,这些法规确保医疗设备的品质标准和安全。在欧盟国家,由于人口老化和需要手术干预的慢性疾病的高盛行率,对内视镜闭合装置的需求稳定。最近的倡议包括欧盟资助创新手术技术和设备改进的研究。中东受益于海湾合作委员会国家丰富的经济,这些国家在卫生基础设施方面进行了大量投资。非洲虽然在卫生设施方面仍不发达,但由于越来越重视卫生改革和外国投资,因此被视为充满希望。由于政府旨在提高医疗保健标准的措施和不断增长的中阶人口,亚太地区内视镜闭合装置市场正在迅速扩大。亚太地区对预防性医疗保健和先进手术设备的投资大幅增加,为该地区的市场成长奠定了基础。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在内视闭合装置市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对内视镜闭合装置市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析也为此细分市场的竞争性质提供了宝贵的见解,包括研究的累积时间、片段化主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在内视镜闭合装置市场中的地位进行全面评估将帮助公司做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[197 Pages Report] The Endoscopic Closure Devices Market size was estimated at USD 509.75 million in 2023 and expected to reach USD 538.15 million in 2024, at a CAGR 5.88% to reach USD 760.93 million by 2030.
Endoscopic closure devices are used to close perforations, incisions, or lumens in the gastrointestinal tract during or after endoscopic procedures. These tools are crucial for procedures such as endoscopic resections, treatment of gastrointestinal defects, and surgeries that require temporary or permanent closure of an opening in the gut wall. The increasing prevalence of gastrointestinal diseases is raising the need for relevant surgeries and, consequently, endoscopic closure devices. Growing preference for minimally invasive procedures that promote faster recovery and reduce hospital stays is expanding the need for endoscopic closure devices. The high cost of advanced endoscopic closure devices hampers the market growth. The growing development of endoscopic closure devices equipped with features that allow integration with health systems for better data management and patient monitoring is expected to create opportunities for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 509.75 million |
Estimated Year [2024] | USD 538.15 million |
Forecast Year [2030] | USD 760.93 million |
CAGR (%) | 5.88% |
Regional Insights
The Americas represents a growing market for endoscopic closure devices due to its advanced healthcare infrastructure and high incidence of gastrointestinal procedures. Consumers in the Americas demonstrate a high awareness of minimally invasive surgeries, subsequently increasing the need for endoscopic closure devices. The endoscopic closure devices market in South America is supported by government and private sector initiatives to reduce surgical times and improve recovery periods. The market across EU countries is driven by stringent EU regulations, which ensure high-quality standards and the safety of medical devices. There is a steady need for endoscopic closure devices in EU countries driven by an aging population and the high prevalence of chronic diseases that require surgical interventions. Recent initiatives include EU funding for research into innovative surgical techniques and device improvements. The Middle East benefits from the affluent economies of GCC countries, which invest heavily in healthcare infrastructure. Africa, while still developing in terms of healthcare facilities, shows promise due to an increasing focus on healthcare reforms and foreign investments. Asia-Pacific's market for endoscopic closure devices is rapidly expanding, driven by government initiatives aimed at improving healthcare standards and a growing middle-class population. Rising substantial investments in preventive medicine and advanced surgical devices in Asia-Pacific are creating a platform for market growth in the region.
Market Insights
The market dynamics represent an ever-changing landscape of the Endoscopic Closure Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Endoscopic Closure Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Endoscopic Closure Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Boston Scientific Expands Endoscopy Capabilities with Apollo Endosurgery Acquisition
Boston Scientific announced its acquisition of Apollo Endosurgery for gastrointestinal and endo bariatric therapies. The acquisition is a strategic enhancement that provides a broader range of endoluminal surgery (ELS) and endo-bariatric solutions. This expansion enriches their product offerings and integrates new expertise into their team, aiming to foster advancements in patient care and medical innovation. [Published On: 2023-04-11]
Substantial Investment Fuels Advancement in Endoscopic Technologies
IQ Endoscopes has garnered a significant EUR 5.2 million investment led by BGF, with contributions from the Development Bank of Wales and other investors. This financial boost is earmarked for enhancing the development and deployment of IQ Endoscope's pioneering device, aimed at transforming early detection and diagnosis of various cancers and gastrointestinal ailments. [Published On: 2023-01-25]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Endoscopic Closure Devices Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Endoscopic Closure Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Apollo Endosurgery, Inc., Boston Scientific Corporation, Conmed Corporation, Cook Group Incorporated, CooperSurgical Inc., Duomed Group, ENDO-FLEX GmbH, EnVision Endoscopy, Johnson & Johnson Services, Inc., Leo Medical Co.,Ltd., Medorah Meditek Pvt. Ltd., Medtronic PLC, Meril Life Sciences Pvt. Ltd., Micro-Tech USA Incorporated, Olympus Corporation, Ovesco Endoscopy AG, Saint-Gobain S.A., SiTime Corporation, Steris plc, and Wuxi Beien Surgery Device Co., Ltd.
Market Segmentation & Coverage